Legislature(2017 - 2018)BARNES 124

04/18/2018 01:00 PM House RESOURCES

Note: the audio and video recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.

Download Mp3. <- Right click and save file as

Audio Topic
01:03:11 PM Start
01:03:43 PM HB28
01:41:46 PM Adjourn
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
*+ HB 28 COSMETICS INGREDIENTS DISCLOSURE TELECONFERENCED
Heard & Held
-- Testimony <Invitation Only> --
+ Bills Previously Heard/Scheduled TELECONFERENCED
             HB 28-COSMETICS INGREDIENTS DISCLOSURE                                                                         
                                                                                                                                
1:03:43 PM                                                                                                                    
                                                                                                                                
CO-CHAIR TARR announced that the  only order of business would be                                                               
HOUSE BILL  NO. 28,  "An Act  relating to  the disclosure  of the                                                               
ingredients in cosmetics; and providing for an effective date."                                                                 
                                                                                                                                
CO-CHAIR  TARR  handed  the  gavel   to  Co-Chair  Josephson  and                                                               
presented HB 28 as prime sponsor.   She spoke to the labeling and                                                               
regulation of cosmetics, personal care  products, and drugs.  She                                                               
gave the example of anti-dandruff  shampoo, which is regulated as                                                               
both a cosmetic  and as a drug.    She presented  a PowerPoint on                                                               
"House  Bill 28  - Cosmetic  Ingredient Disclosure"  [included in                                                               
committee  packet].   She said  that  some slides  were from  the                                                               
Campaign for Safe Cosmetics.                                                                                                    
                                                                                                                                
CO-CHAIR TARR  pointed to the  list of "Chemicals of  Concern" on                                                               
slide 7:                                                                                                                        
                                                                                                                                
        • SODIUM LAURYL/LAURETH SULFATE (SLS AND SLES)                                                                          
        • PETROLEUM/PARAFFIN/MINERAL OIL                                                                                        
        • FORMALDEHYDE                                                                                                          
        • HYDROQUINONE                                                                                                          
        • MERCURY (THIMEROSAL AND MERTHIOLATE)                                                                                  
        • PARABENS    (ISOBUTYLPARABEN,      BUTYLPARABEN,                                                                      
          METHYLPARABEN, PROPYLPARABEN)                                                                                         
        • PHTHALATES (DBP, DEHP, DEP)                                                                                           
        • SYNTHETIC FRAGRANCE/PARFUM                                                                                            
        • PROPYLENE GLYCOL                                                                                                      
        • TRICLOSAN                                                                                                             
                                                                                                                                
CO-CHAIR  TARR drew  attention to  parabens and  phthalates,                                                                    
which were  further examined  on slide 8.   She  pointed out                                                                    
which  products  the compounds  are  found  in, the  related                                                                    
health concerns, what to look  for on the label, and related                                                                    
regulations.                                                                                                                    
                                                                                                                                
1:12:10 PM                                                                                                                    
                                                                                                                                
CO-CHAIR TARR stated that there  is more research in the European                                                               
Union on chemicals than in U.S.   She said that even though there                                                               
is no ban,  there is pressure to  change from the use  of some of                                                               
the compounds by consumer demand.                                                                                               
                                                                                                                                
CO-CHAIR TARR  spoke to  the health concerns  due to  exposure to                                                               
chemicals, listed on slide 10:                                                                                                  
                                                                                                                                
        • Cancer                                                                                                                
        • Reproductive Health disorders                                                                                         
        • Developmental toxicity                                                                                                
        • Allergies                                                                                                             
        • Endocrine disruption                                                                                                  
        • Immunotoxicity                                                                                                        
        • Neurodevelopmental disorders                                                                                          
                                                                                                                                
CO-CHAIR  TARR  spoke to  the  use  of cosmetics  in  cancer                                                                    
patients and  pregnant women.  She  underlined the necessity                                                                    
to  label products  which may  be  unsafe, particularly  for                                                                    
consumers with health needs.                                                                                                    
                                                                                                                                
1:19:11 PM                                                                                                                    
                                                                                                                                
CO-CHAIR TARR  stated the bill  would require all  ingredients be                                                               
listed on  the manufacturer  web site.   She highlighted  that it                                                               
would not  require lists to  be present  on products as  it would                                                               
increase costs to businesses.                                                                                                   
                                                                                                                                
REPRESENTATIVE  BIRCH asked  whether there  would be  a threshold                                                               
number of the elements.                                                                                                         
                                                                                                                                
CO-CHAIR  TARR  pointed  to  page  1, lists  9  through  12.  She                                                               
paraphrased from the section, which read as follows:                                                                            
                                                                                                                                
        9    (b) The list of ingredients in (a) of this                                                                         
          section must list the ingredients in                                                                                  
        10  descending order of the predominance of each                                                                        
          ingredient in the cosmetic, except that a                                                                             
        11  manufacturer may list an ingredient without                                                                         
          respect to order of predominance if the                                                                               
     12 ingredient is present in the cosmetic at a                                                                              
          concentration of one percent or less.                                                                                 
                                                                                                                                
CO-CHAIR  TARR  spoke to  fillers.    She said  that  inexpensive                                                               
herbal supplements can contain fillers.   She added that in China                                                               
lead can  be used in glazes  for houseware products.   She stated                                                               
that  for  endocrine  disruptors,  even  limited  exposure  is  a                                                               
problem.                                                                                                                        
                                                                                                                                
REPRESENTATIVE  BIRCH  asked  whether   the  motivation  for  the                                                               
proposal was due to erroneous labeling.                                                                                         
                                                                                                                                
CO-CHAIR   TARR   answered   the  biggest   difference   concerns                                                               
fragrances.   She  said some  products may  have phthalates,  but                                                               
only list fragrances.                                                                                                           
                                                                                                                                
1:24:49 PM                                                                                                                    
                                                                                                                                
CO-CHAIR   JOSEPHSON   suggested    that   with   the   proposal,                                                               
manufacturer would have to list  more elements; however, consumer                                                               
would have to be vigilant about looking at the labels.                                                                          
                                                                                                                                
CO-CHAIR TARR added that some retailers are self-regulating.                                                                    
                                                                                                                                
CO-CHAIR  JOSEPHSON  mentioned  other current  legislation  which                                                               
would require  the state to  be more vigilant about  oversight of                                                               
wholesale pharmaceuticals.   He referred  to a study  carried out                                                               
in the  state which showed  the chemical blueprint  of individual                                                               
consumers.  He asked whether those chemicals stay in the system.                                                                
                                                                                                                                
CO-CHAIR TARR  answered that some  chemicals bind with  fat cells                                                               
and are  expelled over time.   She  added that another  study had                                                               
found chemicals in  breast milk of far North  mothers which found                                                               
chemicals not available in the area  due to pollution in the air.                                                               
She mentioned persistent organic pollutants (POPs).                                                                             
                                                                                                                                
REPRESENTATIVE RAUSCHER  asked why  the elements are  not already                                                               
required.                                                                                                                       
                                                                                                                                
CO-CHAIR  TARR  answered the  federal  laws  are outdated.    She                                                               
stated that  the earlier  belief was that  some of  the chemicals                                                               
were not  a problem.  She  said recent studies are  being carried                                                               
out to more fully understand the effects.                                                                                       
                                                                                                                                
1:31:11 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE  RAUSCHER   asked  how  far  behind   the  federal                                                               
government is in establishing similar requirements.                                                                             
                                                                                                                                
CO-CHAIR  TARR  suggested  business interests  can  make  changes                                                               
difficult.   She  said states  are taking  action and  may prompt                                                               
federal  action.     She  reiterated  that   new  information  is                                                               
available today.                                                                                                                
                                                                                                                                
REPRESENTATIVE RAUSCHER  asked where to  find out what is  in the                                                               
products he purchases if they are not listed on the packaging.                                                                  
                                                                                                                                
1:35:21 PM                                                                                                                    
                                                                                                                                
CO-CHAIR TARR  pointed to the  web sites in  slide 13.   She said                                                               
overall  health is  based on  multiple factors.  She referred  to                                                               
cancer  survivors and  the need  to  be aware  of ingredients  in                                                               
cosmetics.                                                                                                                      
                                                                                                                                
REPRESENTATIVE  DRUMMOND said  she is  interested in  Alaska-made                                                               
products.  She  mentioned a soap company in her  area which makes                                                               
its products using good ingredients."                                                                                           
                                                                                                                                
CO-CHAIR TARR added  that cosmetic regulations are  over 75 years                                                               
old.  She mentioned that it is a major industry.                                                                                
                                                                                                                                
1:41:04 PM                                                                                                                    
                                                                                                                                
[HB 28 was held over.]                                                                                                          

Document Name Date/Time Subjects
HB028 Sponsor Statement 4.17.2018.pdf HRES 4/18/2018 1:00:00 PM
HB 28
HB028 Version A 4.17.18.PDF HRES 4/18/2018 1:00:00 PM
HB 28
HB028 Sectional Analysis 4.17.18.pdf HRES 4/18/2018 1:00:00 PM
HB 28
HB 28 Fiscal Note - DEC-EH 4.13.18.pdf HRES 4/18/2018 1:00:00 PM
HB 28
HB 28 cosmetic disclosure - sponsor presentation 4.18.18.pdf HRES 4/18/2018 1:00:00 PM
HB 28